Clinical trial

Phase Ib/IIa Trial With AC01 in Patients With HFrEF

NCT05642507

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-02-23

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2023-02-23Date precision: day

Registry last updated2026-05-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

AC01DRUG

Placebo MinitabletsDRUG

Sponsors & collaborators

AnaCardio ABlead sponsor

Mapped research locations

GlasgowUnited Kingdom2 LondonUnited Kingdom1 AmsterdamNetherlands1 StockholmSweden1 GroningenNetherlands1 GothenburgSweden1 RotterdamNetherlands1 MaastrichtNetherlands1 LundSweden1 UtrechtNetherlands1 BresciaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05642507 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.